Biesse SpA
F:BI2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biesse SpA
F:BI2
|
IT |
|
F
|
Fresenius Medical Care AG & Co KGaA
XBER:FME
|
DE |
|
P
|
Pacira Biosciences Inc
XBER:82P
|
US |
Wall St Price Targets
BI2 Price Targets Summary
Biesse SpA
According to Wall Street analysts, the average 1-year price target for
BI2 is 8.93 EUR with a low forecast of 8.26 EUR and a high forecast of 9.81 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BI2's stock price target?
Price Target
8.93
EUR
According to Wall Street analysts, the average 1-year price target for
BI2 is 8.93 EUR with a low forecast of 8.26 EUR and a high forecast of 9.81 EUR.
What is the Revenue forecast for Biesse SpA?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 5%.